← Companies|Aclaris Therapeutics
AC

Aclaris Therapeutics

ACRS·NASDAQWayne PAFounded 201260 employees
Micro CapbiotechPublicDermatologyImmunology
Platform: JAK/MK2
Market Cap
$0.15B
All Drugs
2
Clinical Trials
5
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (ACRS)
Loading ACRS stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
GozederotideACR-1227Preclinical2NanobodyEZH2PCSK9iCMLMM
ACR-6734ACR-6734Approved3ERTPCSK9PI3KiRCC
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)
2027-05-12
ACR-6734 Ph3 Readout
RCC
Ph3 Readout
2027-07-14
ACR-6734 Ph3 Readout
RCC
Ph3 Readout
2029-12-06
Gozederotide Interim
CTCL
Interim
2031-02-06
Gozederotide Interim
MM
Interim
2031-10-19
ACR-6734 Ph3 Readout
RCC
Ph3 Readout